Combined Hyperlipidemia Found to Be Genetically Similar to Isolated Hypertriglyceridemia
Combined hyperlipidemia was found to be similar genetically to isolated hypertriglyceridemia.
Combined hyperlipidemia was found to be similar genetically to isolated hypertriglyceridemia.
In this phase 2 trial, patients with hypercholesterolemia and clinical atherosclerotic cardiovascular disease were recruited from 85 sites across 20 countries.
A long-term very low carbohydrate dietary intervention was associated with a reduction in the concentration of small LDL particles in patients with type 2 diabetes.
Scientific statement by AHA detailing the current understanding of menopause transition and its impact on the risk for postmenopausal cardiovascular disease.
Longer obesity duration is associated with worse cardiometabolic disease risk factors.
Associations between pathogenic variant positivity and 4-single nucleotide polymorphism score were established in patients with familial hypercholesterolemia in response to lipid-lowering therapy.
The use of machine-learning was found to detect familial hypercholesterolemia with high accuracy.
Lipid-lowering pharmacotherapy targeting LDL-C was found to be safe and effective in reducing CV and cerebrovascular events, with similar efficacy in older and younger patients.
Adverse changes in cardiac structure and function were found to be associated with LDL-C and triglycerides plasma concentrations.
Atherosclerotic cardiovascular disease represents the top global cause of morbidity and mortality.